16th ANNUAL EARLY HEARING DETECTION & INTERVENTION MEETING
February 26-28, 2017 • Atlanta, GA

<< BACK TO AGENDA

2/28/2017  |   11:00 AM - 11:30 AM   |  CANCELLED: Testing for Congenital Cytomegalovirus: The Utah EHDI Experience - The First Three+ Years   |  Grand Hall A

CANCELLED: Testing for Congenital Cytomegalovirus: The Utah EHDI Experience - The First Three+ Years

Congenital cytomegalovirus (CMV) is the most common non-hereditary etiology of hearing loss in children, accounting for approximately 33% of pediatric hearing loss in Utah. On July 1, 2013, Utah became the first state in the nation to mandate a cytomegalovirus (CMV) public health initiative. This law included a mandate for testing all babies who fail two newborn hearing screenings for congenital cytomegalovirus prior to 21 days of age. This mandate necessitated a shift in state newborn hearing screening protocols making the “1” in the national 1-3-6 EHDI guidelines no longer the goal in Utah. In order to meet the new CMV testing law, state protocols were revised so that all infants are screened and then re-screened (for those who fail the first screening) by 14 days of age to allow for CMV testing, if needed, to occur within the critical 21-day time window. Data gathered from the first 3+ years of the mandate will be shared. This data will show how the focus on even timelier hearing screening and follow-up necessitated by the CMV testing mandate has increased EHDI milestone attainment in Utah. This positive effect is being seen in infants who received CMV testing whether or not the virus was detected. Challenges overcome and lessons learned to date will be discussed so that other EHDI programs may benefit from Utah’s experience. Come hear some of our unexpected findings, too!

  • Participants will be able to name positive consequences to EHDI milestones as a result of early congenital CMV testing.
  • Participants will be able to discuss data and lessons learned by Utah EHDI during the first 3+ years of their CMV mandate.
  • Participants will be able to apply Utah’s revised newborn hearing screening protocols to their own state’s program to make accommodations for congenital CMV testing.

Presentation:
This presentation has not yet been uploaded or the speaker has opted not to make the presentation available online.

Handouts:
Handout is not Available

Transcripts:
CART transcripts are NOT YET available, but will be posted shortly after the conference


Presenters/Authors

Stephanie Browning McVicar (), Utah Department of Health, smcvicar@utah.gov;
Dr. Stephanie Browning McVicar is the Director of the Early Hearing Detection and Intervention Program, the Children’s Hearing Aid Program, and the Cytomegalovirus Public Health Initiative in Utah. She is Program Manager in the Utah Department of Health's Children with Special Health Care Needs Bureau in Salt Lake City. She is the Audiology Core Faculty member and Director of the Infant-Pediatric Audiology Program for the URLEND (Utah Regional Leadership Education in Neurodevelopmental Disabilities) Program, training future leaders in transdisciplinary family-centered care of children and adolescents with special healthcare needs. Dr. McVicar is a pediatric audiologist, an advocate for CMV testing in newborns, and passionate about the prevention of congenital CMV infection. She is originally from Western New York and has over 25 years of experience and knowledge in Audiology and the management of health care programs in both the public and private sectors. Dr. McVicar serves on the Board of Ethics for the American Speech-Language-Hearing Association.

ASHA DISCLOSURE:

Financial - No relevant financial relationship exist.

Nonfinancial - No relevant nonfinancial relationship exist.